Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 170

1.

Myopathy for the general internist: Statins and much more.

Oddis CV.

Cleve Clin J Med. 2019 Oct;86(10):656-664. doi: 10.3949/ccjm.86gr.19001. Review.

2.

Comparative Profiling of Serum Protein Biomarkers in Rheumatoid Arthritis-associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis.

Kass DJ, Nouraie M, Glassberg MK, Ramreddy N, Fernandez K, Harlow L, Zhang Y, Chen J, Kerr GS, Reimold AM, England BR, Mikuls TR, Gibson KF, Dellaripa PF, Rosas IO, Oddis CV, Ascherman DP.

Arthritis Rheumatol. 2019 Sep 18. doi: 10.1002/art.41123. [Epub ahead of print]

PMID:
31532072
3.

Myositis in clinical practice-relevance of new antibodies.

Moghadam-Kia S, Aggarwal R, Oddis CV.

Best Pract Res Clin Rheumatol. 2018 Dec;32(6):887-901. doi: 10.1016/j.berh.2019.03.012. Epub 2019 Apr 17. Review.

PMID:
31427061
4.

Treatment of calcinosis cutis in systemic sclerosis and dermatomyositis: a review of the literature.

Traineau H, Aggarwal R, Monfort JB, Senet P, Oddis CV, Chizzolini C, Barbaud A, Francès C, Arnaud L, Chasset F.

J Am Acad Dermatol. 2019 Jul 11. pii: S0190-9622(19)32318-7. doi: 10.1016/j.jaad.2019.07.006. [Epub ahead of print]

PMID:
31302187
5.

Refractory Cutaneous Dermatomyositis With Severe Scalp Pruritus Responsive to Apremilast.

Charlton D, Moghadam-Kia S, Smith K, Aggarwal R, English JC 3rd, Oddis CV.

J Clin Rheumatol. 2019 Feb 19. doi: 10.1097/RHU.0000000000000999. [Epub ahead of print] No abstract available.

PMID:
30801336
6.

Management of refractory cutaneous dermatomyositis: potential role of Janus kinase inhibition with tofacitinib.

Moghadam-Kia S, Charlton D, Aggarwal R, Oddis CV.

Rheumatology (Oxford). 2019 Jun 1;58(6):1011-1015. doi: 10.1093/rheumatology/key366.

PMID:
30608616
7.

Anti-MDA5 Antibody Spectrum in Western World.

Moghadam-Kia S, Oddis CV, Aggarwal R.

Curr Rheumatol Rep. 2018 Oct 31;20(12):78. doi: 10.1007/s11926-018-0798-1. Review.

PMID:
30382445
8.

Author Correction: Treatment in myositis.

Oddis CV, Aggarwal R.

Nat Rev Rheumatol. 2018 Oct;14(10):619. doi: 10.1038/s41584-018-0086-5.

PMID:
30206373
9.

The effect of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositis.

Schiffenbauer A, Faghihi-Kashani S, O'Hanlon TP, Flegel WA, Adams SD, Targoff IN, Oddis CV, Ytterberg SR, Aggarwal R, Christopher-Stine L, Shamim EA, Dellaripa PF, Danoff SK, Mammen AL, Miller FW.

Semin Arthritis Rheum. 2018 Dec;48(3):504-512. doi: 10.1016/j.semarthrit.2018.02.003. Epub 2018 Feb 14.

PMID:
29703532
10.

Rituximab in the Treatment of Interstitial Lung Disease Associated with Antisynthetase Syndrome: A Multicenter Retrospective Case Review.

Doyle TJ, Dhillon N, Madan R, Cabral F, Fletcher EA, Koontz DC, Aggarwal R, Osorio JC, Rosas IO, Oddis CV, Dellaripa PF.

J Rheumatol. 2018 Jun;45(6):841-850. doi: 10.3899/jrheum.170541. Epub 2018 Apr 1.

11.

Treatment in myositis.

Oddis CV, Aggarwal R.

Nat Rev Rheumatol. 2018 May;14(5):279-289. doi: 10.1038/nrrheum.2018.42. Epub 2018 Mar 29. Review. Erratum in: Nat Rev Rheumatol. 2018 Oct;14(10):619.

PMID:
29593343
12.

Drs. Aggarwal and Oddis reply.

Aggarwal R, Oddis CV.

J Rheumatol. 2018 Mar;45(3):446. doi: 10.3899/jrheum.171430. No abstract available.

PMID:
29496924
13.

Response to: 'Elephant in the room' by Hartung et al.

Aggarwal R, Oddis CV.

Ann Rheum Dis. 2019 Feb;78(2):e12. doi: 10.1136/annrheumdis-2018-213020. Epub 2018 Feb 22. No abstract available.

PMID:
29472363
14.

Efficacy and safety of adrenocorticotropic hormone gel in refractory dermatomyositis and polymyositis.

Aggarwal R, Marder G, Koontz DC, Nandkumar P, Qi Z, Oddis CV.

Ann Rheum Dis. 2018 May;77(5):720-727. doi: 10.1136/annrheumdis-2017-212047. Epub 2017 Dec 13.

PMID:
29237618
15.

Exploration of the MUC5B promoter variant and ILD risk in patients with autoimmune myositis.

Johnson C, Rosen P, Lloyd T, Horton M, Christopher-Stine L, Oddis CV, Mammen AL, Danoff SK.

Respir Med. 2017 Sep;130:52-54. doi: 10.1016/j.rmed.2017.07.010. Epub 2017 Jul 17.

16.

EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report.

Bottai M, Tjärnlund A, Santoni G, Werth VP, Pilkington C, de Visser M, Alfredsson L, Amato AA, Barohn RJ, Liang MH, Singh JA, Aggarwal R, Arnardottir S, Chinoy H, Cooper RG, Danko K, Dimachkie MM, Feldman BM, García-De La Torre I, Gordon P, Hayashi T, Katz JD, Kohsaka H, Lachenbruch PA, Lang BA, Li Y, Oddis CV, Olesinka M, Reed AM, Rutkowska-Sak L, Sanner H, Selva-O'Callaghan A, Wook Song Y, Vencovsky J, Ytterberg SR, Miller FW, Rider LG, Lundberg IE; International Myositis Classification Criteria Project consortium, the Euromyositis register and the Juvenile Dermatomyositis Cohort Biomarker Study and Repository (JDRG) (UK and Ireland) .

RMD Open. 2017 Nov 14;3(2):e000507. doi: 10.1136/rmdopen-2017-000507. eCollection 2017.

17.

2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups.

Lundberg IE, Tjärnlund A, Bottai M, Werth VP, Pilkington C, de Visser M, Alfredsson L, Amato AA, Barohn RJ, Liang MH, Singh JA, Aggarwal R, Arnardottir S, Chinoy H, Cooper RG, Dankó K, Dimachkie MM, Feldman BM, Garcia-De La Torre I, Gordon P, Hayashi T, Katz JD, Kohsaka H, Lachenbruch PA, Lang BA, Li Y, Oddis CV, Olesinska M, Reed AM, Rutkowska-Sak L, Sanner H, Selva-O'Callaghan A, Song YW, Vencovsky J, Ytterberg SR, Miller FW, Rider LG; International Myositis Classification Criteria Project Consortium, the Euromyositis Register, and the Juvenile Dermatomyositis Cohort Biomarker Study and Repository (UK and Ireland).

Arthritis Rheumatol. 2017 Dec;69(12):2271-2282. doi: 10.1002/art.40320. Epub 2017 Oct 27. Erratum in: Arthritis Rheumatol. 2018 Sep;70(9):1532.

18.

2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups.

Lundberg IE, Tjärnlund A, Bottai M, Werth VP, Pilkington C, Visser M, Alfredsson L, Amato AA, Barohn RJ, Liang MH, Singh JA, Aggarwal R, Arnardottir S, Chinoy H, Cooper RG, Dankó K, Dimachkie MM, Feldman BM, Torre IG, Gordon P, Hayashi T, Katz JD, Kohsaka H, Lachenbruch PA, Lang BA, Li Y, Oddis CV, Olesinska M, Reed AM, Rutkowska-Sak L, Sanner H, Selva-O'Callaghan A, Song YW, Vencovsky J, Ytterberg SR, Miller FW, Rider LG; International Myositis Classification Criteria Project consortium, The Euromyositis register and The Juvenile Dermatomyositis Cohort Biomarker Study and Repository (JDRG) (UK and Ireland).

Ann Rheum Dis. 2017 Dec;76(12):1955-1964. doi: 10.1136/annrheumdis-2017-211468. Epub 2017 Oct 27. Erratum in: Ann Rheum Dis. 2018 Sep;77(9):e64.

19.

Muscle involvement in systemic sclerosis: points to consider in clinical trials.

Walker UA, Clements PJ, Allanore Y, Distler O, Oddis CV, Khanna D, Furst DE.

Rheumatology (Oxford). 2017 Sep 1;56(suppl_5):v38-v44. doi: 10.1093/rheumatology/kex196. Review.

20.

2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects.

Rider LG, Ruperto N, Pistorio A, Erman B, Bayat N, Lachenbruch PA, Rockette H, Feldman BM, Huber AM, Hansen P, Oddis CV, Lundberg IE, Amato AA, Chinoy H, Cooper RG, Chung L, Danko K, Fiorentino D, García-De la Torre I, Reed AM, Wook Song Y, Cimaz R, Cuttica RJ, Pilkington CA, Martini A, van der Net J, Maillard S, Miller FW, Vencovsky J, Aggarwal R; International Myositis Assessment and Clinical Studies Group and the Paediatric Rheumatology International Trials Organisation.

Rheumatology (Oxford). 2017 Nov 1;56(11):1884-1893. doi: 10.1093/rheumatology/kex226.

21.

Pulmonary Pathologic Manifestations of Anti-Alanyl-tRNA Synthetase (Anti-PL-12)-Related Inflammatory Myopathy.

Schneider F, Yousem SA, Oddis CV, Aggarwal R.

Arch Pathol Lab Med. 2018 Feb;142(2):191-197. doi: 10.5858/arpa.2017-0010-OA. Epub 2017 Oct 2.

PMID:
28967806
22.

Drs. Aggarwal and Oddis reply.

Aggarwal R, Oddis CV.

J Rheumatol. 2017 Oct;44(10):1565. doi: 10.3899/jrheum.170480. No abstract available.

PMID:
28966174
23.

Biologics for idiopathic inflammatory myopathies.

Moghadam-Kia S, Aggarwal R, Oddis CV.

Curr Opin Rheumatol. 2017 Nov;29(6):645-651. doi: 10.1097/BOR.0000000000000432. Review.

PMID:
28817464
24.

2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.

Aggarwal R, Rider LG, Ruperto N, Bayat N, Erman B, Feldman BM, Oddis CV, Amato AA, Chinoy H, Cooper RG, Dastmalchi M, Fiorentino D, Isenberg D, Katz JD, Mammen A, de Visser M, Ytterberg SR, Lundberg IE, Chung L, Danko K, García-De la Torre I, Song YW, Villa L, Rinaldi M, Rockette H, Lachenbruch PA, Miller FW, Vencovsky J; International Myositis Assessment and Clinical Studies Group and the Paediatric Rheumatology International Trials Organisation.

Ann Rheum Dis. 2017 May;76(5):792-801. doi: 10.1136/annrheumdis-2017-211400.

25.

2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.

Aggarwal R, Rider LG, Ruperto N, Bayat N, Erman B, Feldman BM, Oddis CV, Amato AA, Chinoy H, Cooper RG, Dastmalchi M, Fiorentino D, Isenberg D, Katz JD, Mammen A, de Visser M, Ytterberg SR, Lundberg IE, Chung L, Danko K, García-De la Torre I, Song YW, Villa L, Rinaldi M, Rockette H, Lachenbruch PA, Miller FW, Vencovsky J; International Myositis Assessment and Clinical Studies Group and the Paediatric Rheumatology International Trials Organisation.

Arthritis Rheumatol. 2017 May;69(5):898-910. doi: 10.1002/art.40064. Epub 2017 Apr 6.

26.

Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis.

Moghadam-Kia S, Oddis CV, Sato S, Kuwana M, Aggarwal R.

J Rheumatol. 2017 Mar;44(3):319-325. doi: 10.3899/jrheum.160682. Epub 2017 Jan 15.

PMID:
28089977
27.

Myositis-associated usual interstitial pneumonia has a better survival than idiopathic pulmonary fibrosis.

Aggarwal R, McBurney C, Schneider F, Yousem SA, Gibson KF, Lindell K, Fuhrman CR, Oddis CV.

Rheumatology (Oxford). 2017 Mar 1;56(3):384-389. doi: 10.1093/rheumatology/kew426.

PMID:
28082622
28.

A Negative Antinuclear Antibody Does Not Indicate Autoantibody Negativity in Myositis: Role of Anticytoplasmic Antibody as a Screening Test for Antisynthetase Syndrome.

Aggarwal R, Dhillon N, Fertig N, Koontz D, Qi Z, Oddis CV.

J Rheumatol. 2017 Feb;44(2):223-229. doi: 10.3899/jrheum.160618. Epub 2016 Dec 1.

PMID:
27909085
29.

Cutaneous improvement in refractory adult and juvenile dermatomyositis after treatment with rituximab.

Aggarwal R, Loganathan P, Koontz D, Qi Z, Reed AM, Oddis CV.

Rheumatology (Oxford). 2017 Feb;56(2):247-254. doi: 10.1093/rheumatology/kew396. Epub 2016 Nov 11.

30.

The Legacy of Maurice Raynaud.

Prabhu AV, Oddis CV.

JAMA Dermatol. 2016 Nov 1;152(11):1253. doi: 10.1001/jamadermatol.2016.0010. No abstract available.

PMID:
27829111
31.

The Rise of Henri-Alexandre Danlos and His Contributions to Dermatologic Therapeutics and Radiation Research.

Patel P, Prabhu AV, Oddis CV.

JAMA Dermatol. 2016 Oct 1;152(10):1113. doi: 10.1001/jamadermatol.2015.6237. No abstract available.

PMID:
27732731
32.

Rituximab-induced neutropenia in a patient with inflammatory myopathy and systemic sclerosis overlap disease.

Akram Q, Roberts M, Oddis C, Herrick A, Chinoy H.

Reumatologia. 2016;54(1):35-7. doi: 10.5114/reum.2016.58760. Epub 2016 Mar 24.

33.

Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab.

Aggarwal R, Oddis CV, Goudeau D, Koontz D, Qi Z, Reed AM, Ascherman DP, Levesque MC.

Rheumatology (Oxford). 2016 Sep;55(9):1710. doi: 10.1093/rheumatology/kew275. Epub 2016 Jul 6. No abstract available.

PMID:
27383242
34.

Update on the pharmacological treatment of adult myositis.

Oddis CV.

J Intern Med. 2016 Jul;280(1):63-74. doi: 10.1111/joim.12511. Epub 2016 Apr 20. Review.

35.

Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab.

Aggarwal R, Oddis CV, Goudeau D, Koontz D, Qi Z, Reed AM, Ascherman DP, Levesque MC.

Rheumatology (Oxford). 2016 Jun;55(6):991-9. doi: 10.1093/rheumatology/kev444. Epub 2016 Feb 16. Erratum in: Rheumatology (Oxford). 2016 Sep;55(9):1710.

36.

Modern Therapies for Idiopathic Inflammatory Myopathies (IIMs): Role of Biologics.

Moghadam-Kia S, Oddis CV, Aggarwal R.

Clin Rev Allergy Immunol. 2017 Feb;52(1):81-87. doi: 10.1007/s12016-016-8530-2. Review.

37.

Approach to asymptomatic creatine kinase elevation.

Moghadam-Kia S, Oddis CV, Aggarwal R.

Cleve Clin J Med. 2016 Jan;83(1):37-42. doi: 10.3949/ccjm.83a.14120. Review.

38.

Histopathologic Findings in 5 Patients With Hypomyopathic Dermatomyositis: The Importance of MHC-1 Expression on Myofibers.

El-Dokla AM, Aggarwal R, Oddis CV, Ali ST, Lacomis D.

J Clin Neuromuscul Dis. 2015 Dec;17(2):52-8. doi: 10.1097/CND.0000000000000098.

PMID:
26583490
39.

Immune-mediated statin myopathy.

Loganathan P, Oddis CV, Aggarwal R.

Expert Rev Clin Immunol. 2016;12(1):33-8. doi: 10.1586/1744666X.2016.1103181. Epub 2015 Oct 30. Review.

PMID:
26515829
40.

Interferon-regulated chemokine score associated with improvement in disease activity in refractory myositis patients treated with rituximab.

López De Padilla CM, Crowson CS, Hein MS, Strausbauch MA, Aggarwal R, Levesque MC, Ascherman DP, Oddis CV, Reed AM.

Clin Exp Rheumatol. 2015 Sep-Oct;33(5):655-63. Epub 2015 Oct 5.

PMID:
26446265
41.

Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis.

Moghadam-Kia S, Oddis CV, Sato S, Kuwana M, Aggarwal R.

Arthritis Care Res (Hoboken). 2016 May;68(5):689-94. doi: 10.1002/acr.22728.

42.

Biologic predictors of clinical improvement in rituximab-treated refractory myositis.

Reed AM, Crowson CS, Hein M, de Padilla CL, Olazagasti JM, Aggarwal R, Ascherman DP, Levesque MC, Oddis CV; RIM Study Group.

BMC Musculoskelet Disord. 2015 Sep 17;16:257. doi: 10.1186/s12891-015-0710-3.

43.

Treatment of inflammatory myopathy: emerging therapies and therapeutic targets.

Moghadam-Kia S, Aggarwal R, Oddis CV.

Expert Rev Clin Immunol. 2015;11(11):1265-75. doi: 10.1586/1744666X.2015.1082908. Epub 2015 Aug 27. Review.

44.

Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers.

Doyle TJ, Patel AS, Hatabu H, Nishino M, Wu G, Osorio JC, Golzarri MF, Traslosheros A, Chu SG, Frits ML, Iannaccone CK, Koontz D, Fuhrman C, Weinblatt ME, El-Chemaly SY, Washko GR, Hunninghake GM, Choi AM, Dellaripa PF, Oddis CV, Shadick NA, Ascherman DP, Rosas IO.

Am J Respir Crit Care Med. 2015 Jun 15;191(12):1403-12. doi: 10.1164/rccm.201411-1950OC.

45.

The pulmonary histopathology of anti-KS transfer RNA synthetase syndrome.

Schneider F, Aggarwal R, Bi D, Gibson K, Oddis C, Yousem SA.

Arch Pathol Lab Med. 2015 Jan;139(1):122-5. doi: 10.5858/arpa.2013-0667-OA.

PMID:
25549148
46.

Anti-signal recognition particle autoantibody ELISA validation and clinical associations.

Aggarwal R, Oddis CV, Goudeau D, Fertig N, Metes I, Stephens C, Qi Z, Koontz D, Levesque MC.

Rheumatology (Oxford). 2015 Jul;54(7):1194-9. doi: 10.1093/rheumatology/keu436. Epub 2014 Dec 17.

47.

Biomarkers of rheumatoid arthritis-associated interstitial lung disease.

Chen J, Doyle TJ, Liu Y, Aggarwal R, Wang X, Shi Y, Ge SX, Huang H, Lin Q, Liu W, Cai Y, Koontz D, Fuhrman CR, Golzarri MF, Liu Y, Hatabu H, Nishino M, Araki T, Dellaripa PF, Oddis CV, Rosas IO, Ascherman DP.

Arthritis Rheumatol. 2015 Jan;67(1):28-38. doi: 10.1002/art.38904.

48.

Anti-citrullinated heat shock protein 90 antibodies identified in bronchoalveolar lavage fluid are a marker of lung-specific immune responses.

Harlow L, Gochuico BR, Rosas IO, Doyle TJ, Osorio JC, Travers TS, Camacho CC, Oddis CV, Ascherman DP.

Clin Immunol. 2014 Nov;155(1):60-70. doi: 10.1016/j.clim.2014.08.004. Epub 2014 Aug 19.

49.

Novel assessment tools to evaluate clinical and laboratory responses in a subset of patients enrolled in the Rituximab in Myositis trial.

Rider LG, Yip AL, Horkayne-Szakaly I, Volochayev R, Shrader JA, Turner ML, Kong HH, Jain MS, Jansen AV, Oddis CV, Fleisher TA, Miller FW.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5):689-96. Epub 2014 Jul 28.

50.

Pulmonary pathologic manifestations of anti-glycyl-tRNA synthetase (anti-EJ)-related inflammatory myopathy.

Schneider F, Yousem SA, Bi D, Gibson KF, Oddis CV, Aggarwal R.

J Clin Pathol. 2014 Aug;67(8):678-83. doi: 10.1136/jclinpath-2014-202367. Epub 2014 Jun 2.

PMID:
24891607

Supplemental Content

Support Center